Skip to main content

Bone Loss clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

    Sorry, not currently recruiting here

    Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.

    San Francisco, California and other locations

Last updated: